Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication

Journal of Virology

Volumn 74, Issue 11, 2000, Pages 4979-4987

  Gribaudo, Giorgio ^a   Riera, Ludovica ^a   Lembo, David ^a   De Andrea, Marco ^c   Gariglio, Marisa ^c   Rudge, Thomas L ^d   Johnson, Lee F ^d   Landolfo, Santo ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID DERIVATIVE; IMMEDIATE EARLY PROTEIN; MESSENGER RNA; QUINAZOLINE DERIVATIVE; RALTITREXED; THYMIDYLATE SYNTHASE; TRANSCRIPTION FACTOR E2F;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA SYNTHESIS; EMBRYO; FIBROBLAST; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSACTIVATION; VIRUS REPLICATION;

3T3 CELLS; ANIMALS; BINDING SITES; CARRIER PROTEINS; CELL CYCLE PROTEINS; DNA REPLICATION; DNA, VIRAL; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMEDIATE-EARLY PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUROMEGALOVIRUS; PROMOTER REGIONS (GENETICS); QUINAZOLINES; THIOPHENES; THYMIDYLATE SYNTHASE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0034024480     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.11.4979-4987.2000     Document Type: Article

References (63)

1. Abken, H., and B. Reifenrath. 1992. A procedure to standardize CAT reporter gene assay. Nucleic Acids Res. 20:3527.
2. Alonso, S., A. Minty, Y. Bourlet, and M. Buckingham. 1986. Comparison of three actin-coding sequences in the mouse: evolutionary relationships between the actin genes of warm-blooded vertebrates. J. Mol. Evol. 23:11-22.
3. Ash, J., W.-C. Liao, Y. Ke, and L. F. Johnson. 1995. Regulation of mouse thymidylate synthase gene expression in growth-stimulated cells: upstream S phase control elements are indistinguishable from the essential promoter elements. Nucleic Acids Res. 23:4649-4656.
4. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1994. Current protocols in molecular biology, vol. 1. John Wiley & Sons, Inc. New York, N.Y.
5. Barredo, J., and R. G. Moran. 1992. Determinants of antifolate cytotoxicity: folylpolyglutamate synthetase activity during cellular proliferation and development. Mol. Pharmacol. 42:687-694.
6. Benson, J. D., and E.-S. Huang. 1990. Human cytomegalovirus induces expression of cellular topoisomerase II. J. Virol. 64:9-15.
7. Biron, K. K., J. A. Fyfe, S. C. Stanat, L. K. Leslie, J. A. Sorrell, C. U. Lambe, and D. M. Coen. 1986. A human cytomegalovirus mutant resistant to the nucleoside analog 9-[2-hydroxy-1-(hydroxymethyl)ethoxy]methylguanine (BW B759U) induces reduced levels of BW B759U triphosphate. Proc. Natl. Acad. Sci. USA 83:8769-8773.
8. Blackledge, G. 1998. New developments in cancer treatment with the novel thymidylate synthase inhibitor raltitrexed ('Tomudex'). Br. J. Cancer 77:29-37.
9. Boldogh, I., S. AbuBakar, and T. Albrecht. 1990. Activation of protooncogenes: an immediate early event in human cytomegalovirus infection. Science 247:961-964.
10. Boldogh, I., S. AbuBakar, C. Z. Deng, and T. Albrecht. 1991. Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus. J. Virol. 65:1568-1571.
11. Boldogh, I., S. AbuBakar, D. Millinoff, C. Z. Deng, and T. Albrecht. 1991. Cellular oncogenes activation by human cytomegalovirus. Lack of correlation with virus infectivity and immediate early gene expression. Arch. Virol. 118:163-177.
12. Boyle, K. A., R. L. Pietropaolo, and T. Compton. 1999. Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. Mol. Cell. Biol. 19:3607-3613.
13. Bresnahan, W. A., E. A. Thompson, and T. Albrecht. 1997: Human cytomegalovirus infection results in altered Cdk2 subcellular localization. J. Gen. Virol. 78:1993-1997.
14. 1. Virology 224:150-160.
15. Bresnahan, W. A., T. Albrecht, and E. A. Thompson. 1998. The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein. J. Biol. Chem. 273:22075-22082.
16. Chee, M. S., A. T. Bankier, S. Beck, R. Bohni, C. M. Brown, R. Cerny, T. Horsnell, C. A. Hutchison III, T. Kouzarides, J. A. Martignetti, E. Preddie, S. C. Satchwell, P. Tomlinson, K. M. Weston, and B. G. Barrell. 1990. Analysis of the protein-coding content of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125-169.
17. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18:5294-5299.
18. Deng, T., Y. Li, K. Yolliff, and L. F. Johnson. 1989. The mouse thymidylate synthase promoter: essential elements are in close proximity to the transcriptional initiation sites. Mol. Cell. Biol. 9:4079-4082.
19. 1/S transition. J. Virol. 71:1629-1634
20. Estes, J. E., and E.-S. Huang. 1977. Stimulation of cellular thymidine kinase by human cytomegalovirus. J. Virol. 24:13-21.
21. Gariglio, M., P. Foresta, C. Sacchi, M. Lembo, L. Hertel, and S. Landolfo. 1997. Suppression of high mobility group protein T160 expression impairs mouse cytomegalovirus replication. J. Gen. Virol. 78:665-670.
22. Geng, Y., and L. F. Johnson. 1993. Lack of an initiator element is responsible for multiple transcriptional initiation sites of the TATA-less mouse thymidylate synthase promoter. Mol. Cell. Biol. 13:4894-4903.
23. Gribaudo, G., S. Ravaglia, L. Guandalini, R. Cavallo, M. Gariglio, and S. Landolfo. 1996. The murine cytomegalovirus immediate early 1 protein stimulates NF-kB κctivity by transactivating the NF-κB p105/p50 promoter. Virus Res. 45:15-27.
24. Gribaudo, G., S. Ravaglia, M. Gaboli, M. Gariglio, R. Cavallo, and S. Landolfo. 1995. Interferon-α inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-κB activity. Virology 211: 251-260.
25. Hayhurst, G. P., L. A. Bryant, R. C. Caswell, S. M. Walker, and J. H. Sinclair. 1995. CCAAT box-dependent activation of the TATA-less human DNA polymerase α promoter by the human cytomegalovirus 72-kilodalton major immediate-early protein. J. Virol. 69:182-188.
26. Hilton, J. G., B. A. Cooper, and D. S. Rosenblatt. 1979. Folate polyglutamate synthesis and turnover in cultured human fibroblasts. J. Biol. Chem. 254: 8393-8403.
27. Isom, H. C. 1979. Stimulation of ornithine decarboxylase by human cytomegalovirus. J. Gen. Virol. 42:265-278.
28. Jackman, A. L., and W. Gibson. 1995. Polyglutamation of the thymidylate synthase inhibitor, ZD1694 (Tomudex) in mormal mouse tissues. Proc. Am. Assoc. Cancer Res. 36:376.
29. Jackman, A. L., G. A. Taylor, W. Gibson, R. Kimbell, M. Brown, A. H. Calvert, I. Judson, and L. R. Hughes. 1991. ZD1694, aquinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study. Cancer Res. 51:5579-5586.
30. Jault, F. M., J.-M. Jault, F. Ruchti, E. A. Fortunato, C. Clark, J. Corbeil, D. D. Richman, and D. H. Spector. 1995. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J. Virol. 69:6697-6704.
31. Johnson, L. F. 1994. Posttranscriptional regulation of thymidylate synthase gene expression. J. Cell. Biochem. 54:387-392.
32. Johnston, P. G., C.-M. Liang, S. Henry, B. A. Chabner, and C. J. Allegra. 1991. Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue. Cancer Res. 51:6668-6676.
33. Johnston, P. G., J. C. Drake, J. Trepel, and C. J. Allegra. 1992. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines. Cancer Res. 52:4306-4312.
34. Ke, Y., J. Ash, and L. F. Johnson. 1996. Splicing signals are required for S-phase regulation of the mouse thymidylate synthase gene. Mol. Cell. Biol. 16:376-383.
35. Keil, G. M, A. Ebeling-Keil, and U. H. Koszinowski. 1987. Sequence and structural organization of murine cytomegalovirus immediate-early gene 1. J. Virol. 61:1901-1908.
36. r murine cytomegalovirus immediate-early protein activates gene transcription. J. Virol. 58:59-66.
37. Kucera, R., and H. Paulus. 1986. Localization of the deoxyribonucleotide biosynthetic enzymes ribonucleotide reductase and thymidylate synthase in mouse L cells. Exp. Cell Res. 167:417-428.
38. Lembo, D., A. Angeretti, M. Gariglio, and S. Landolfo. 1998. Murine cytomegalovirus induces expression and enzyme activity of dihydrofolate reductase in quiescent cells. J. Gen. Virol. 78:2803-2808.
39. Li, Y., D. Li, K. Osborn, and L. F. Johnson. 1991. The 5′-flanking region of the mouse thymidylate synthase gene is necessary but not sufficient for normal regulation in growth-stimulated cells. Mol. Cell. Biol. 11:1023-1029.
40. 1 to S. J. Virol. 70:8850-8857.
41. Margolis M. J., S. Pajovic, E. L. Wong, M. Wade, R. Jupp, J. A. Nelson, and J. C. Azizkhan. 1995. Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription. J. Virol. 69:7754-7767.
42. McGuire, J. J., and J. R. Bertino. 1981. Enzymatic synthesis and function of folylpolyglutamates. Mol. Cell. Biochem. 38:19-48.
43. Messerle, M., B. Buhler, G. M. Keil, and U. H. Koszinowski. 1992. Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3. J. Virol. 66:27-36.
44. Mocarski, E. S. 1996. Cytomegalovirus and their replication, p. 2447-2492. In B. N. Fields, D. M. Knipe, P. H. Howley, R. M. Chanock, J. L. Menlick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
45. Moran, R. G., C. P. Spears, and C. Heidelberger. 1979 Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determinattion of 5-fluoro-2′-deoxyuridylate, 2′-deoxyuridylate, and thymidylate synthetase. Proc. Natl. Acad. Sci. USA 76:1456-1460.
46. Moran, R. G., W. C. Werkheiser, and S. F. Zakrewski. 1976. Folate metabolism in mammalian cells in culture. J. Biol. Chem. 251:3569-3575.
47. Panjovic, S., E. L. Wong, A. R. Black, and J. C. Azizkhan. 1997. Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins. Mol. Cell. Biol. 17:6459-6464.
48. Pauwels, R., J. Balzarini, M. Baba, R. Snoeck, D. Schols, P. Hederwijin, J. Desmyter, and E. De Clerq. 1988. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20:309-321.
49. Perryman, S. M., C. Rossana, T. Deng, E. F. Vanin, and L. F. Johnson. 1986. Sequence of a cDNA for mouse thymidylate synthase reveals striking similarity with the prokaryotic enzyme. Mol. Biol. Evol. 3:313-321.
50. Poma, E. E., T. F. Kowalik, L. Zhu, J. H. Sinclair and E.-S. Huang. 1996. The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. J. Virol. 70:7867-7877.
51. Rawlinson, W. D., H. E. Farrell, and B. G. Barrell. 1996 Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70:8833-8849.
52. Salvant, B, S., E. A. Fortunato, and D. H. Spector. 1998. Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J. Virol. 72:3729-3741.
53. Samsonoff, W. A., J. Reston, M. McKee, B. O'Connor, J. Galivan, G. Maley, and F. Maley. 1997. Intracellular location of thymidylate synthase and its state of phosphorylation. J. Biol. Chem. 272:13281-13285.
54. r murine cytomegalovirus immediate-early protein stimulates c-fos expression and cellular DNA synthesis. J. Virol. 62:3341-3347.
55. Shibui, S., T. Hoshino, K. Iwasaki, K. Nomura, and M. M. Jastreboff. 1989. Cell cycle phase dependent emergence of thymidylate synthase studied by monoclonal antibody (M-TS-49). Cell Tissue Kinet. 22:259-268.
56. Spears, C. P., A. H. Shahinian, R. G. Moran, C. Heidelberger, and T. H. Corbett. 1982. In vivo kinetics of thymidylate synthetase inhibition in 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Cancer Res. 42:450-456.
57. Suzuki, S., M. Saneyoshi, C. Nakayama, Y. Nishiyama, and S. Yoshida. 1985. Mechanism of selective inhibition of human cytomegalovirus replication by 1-β-D-arabinofuranosyl-5-fluorouracil. Antimicrob. Agents Chemother. 28: 326-330.
58. Synold, T. W., E. M. Willits, and J. C. Barredo. 1996. Role of folylpolyglutamate synthetase (FPGS) in antifolate chemotherapy: a biomedical and clinical update. Leuk. Lymphoma 21:9-15.
59. Wade, M., T. F. Kowalik, M. Mudryj, E.-S. Huang, and J. C. Azizkhan. 1992 E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection. Mol. Cell. Biol. 12:4364-4374.
60. 1. J. Virol. 73:9274-9283.
61. Yurochko, A. D., E.-S. Hwang, L. Rasmussen, S. Keay, L. Pereira, and E.-S. Huang. 1997. The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J. Virol. 71:5051-5059.
62. Yurochko, A. D., M. W. Mayo, E. E. Poma, A. S. Baldwin, Jr., and E.-S. Huang. 1997. Induction of the transcription factor SP1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters. J. Virol. 71:4638-4648.
63. Yurochko, A. D., T. F. Kowalik, S. M. Huong, and E.-S. Huang. 1995. Human cytomegalovirus upregulates NF-κB activity by transactivating the NF-κB p105/p50 and p65 promoter. J. Virol. 69:5391-5400.